Cytori Announces Presentation at Biotech Showcase™ on January 13 Print
Business Wire
Tuesday, 07 January 2014 02:06
Cytori Therapeutics, Inc.
Megan McCormick, +1.858.875.5279
mmccormick@cytori.com
Logo
Jan. 7, 2014 13:00 UTC

Cytori Announces Presentation at Biotech Showcase™ on January 13

Biotech Showcase 2014

SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will webcast their corporate presentation at the Biotech Showcaseat 11:00 AM PT (2:00 PM ET) on Monday, January 13. The presentation will be held in the Mission II room of the Parc 55 Wyndham Hotel in San Francisco.

The presentation webcast may be accessed on the "Webcasts" page of the Investor Relations section of the Company's website. The webcast can be accessed live and will be available for replay approximately one hour after the presentation on the Company's website.

In addition, Cytori’s CEO Chris Calhoun will be participating in a panel at the Alliance for Regenerative Medicine’s (ARM) State of the Industry Briefing. The panel discussion will be filmed and will be made available at a later date on the ARM website. The details are as follows:

Biotech Showcase™ 2014: ARM’s Regenerative Medicine State of the Industry Briefing

Panel:                 Recent Financings in the Sector
Date: January 13, 2014
Time: 9:00 – 9:45 AM PT
Location: Parc 55 Wyndham, 55 Cyril Magnin Street, San Francisco, CA
Cyril Magnin Ballroom - 4th Floor
 

About Cytori

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution System product family. www.cytori.com

Contacts

Cytori Therapeutics, Inc.
Megan McCormick, +1.858.875.5279
mmccormick@cytori.com


Source: Cytori Therapeutics, Inc.




BiomedReports is not paid or compensated by newswires to disseminate or report news and
developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and

Error. Page cannot be displayed. Please contact your service provider for more details. (32)

investor relation services from various entities and
firms. Full disclosures should be read in the 'About Us Section'.


Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
  BMR:1